EUVIMEDEUVIMED entdecken
Crossref

Tumor Microenvironmental Stimuli‐Responsive Linear‐Dendritic Polymeric Conjugate as Potential Nanomedicine

Yongchao Wang, Pan Xiang, Yinggang Li, Yahui Wu, Hao Cai, Kui Luo iD

Macromolecular Rapid Communications · 2026-06 · 47 (11)

DOI: 10.1002/marc.70258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Macromolecular Rapid Communications, online erschienen am 15.03.2026. Verfasst von Yongchao Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Institution of Radiology and Medical Imaging, Huaxi MR Research Center (HMRRC), Department of Thoracic Surgery and Institute…. Hauptthemen laut MEDLINE: Doxorubicin, Tumor Microenvironment, Dendrimers, Nanomedicine. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Natural Science Foundation of China, Department of Science and Technology of Sichuan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A linear‐dendritic polymer has been explored as a drug delivery vehicle for cancer therapy. In this study, we successfully prepared a tumor microenvironment‐responsive, dendronized and block poly[ N ‐(2‐hydroxypropyl) methacrylamide] (polyHPMA)‐based copolymer‐doxorubicin conjugate (pHPMA‐block‐pDendron‐DOX) via two‐step reversible addition‐fragmentation chain transfer (RAFT) polymerization. The conjugate self‐assembled into nanoparticles (NPs). Due to the presence of the Gly‐Phe‐Leu‐Gly (GFLG) tetrapeptide and the hydrazone bond in the structure of the conjugate, cathepsin B‐responsive degradation and pH‐responsive drug release were realized within the tumor microenvironment. The NPs displayed a distinctive cytotoxic effect on 4T1 cells after internalization through endocytosis pathways. Significant improvements in the accumulation of doxorubicin (DOX) from the NPs were observed at the tumor site in a 4T1 murine breast cancer xenograft model, leading to promising anti‐cancer effects. In addition, the side effects of DOX were significantly diminished in the NPs at a high dose. The prepared linear‐dendritic conjugate could be used as an efficient and safe nanomedicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinTumor MicroenvironmentDendrimersNanomedicinePolymersAntineoplastic AgentsDrug CarriersAntibiotics, AntineoplasticAnimalsMiceFemaleNanoparticlesCell Line, TumorMice, Inbred BALB CDrug LiberationHumansDrug Delivery SystemsHydrogen-Ion ConcentrationCell Survival

Stichwörter der Autor:innen

anticancerdrug delivery systemenzyme‐sensitivelinear‐dendritic polymerpH‐sensitive

Substanzen

DoxorubicinDendrimersPolymersAntineoplastic AgentsDrug CarriersAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Department of Radiology, Institution of Radiology and Medical Imaging, Huaxi MR Research Center (HMRRC), Department of Thoracic Surgery and Institute of Thoracic Oncology, Frontiers Science Center for Disease-Related Mo…
  • Psychoradiology Key Laboratory of Sichuan Province, West China Hospital, Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Sichuan University, Chengdu, China.

ORCID-Profile: Kui Luo

Förderung

  • Natural Science Foundation of China
  • Department of Science and Technology of Sichuan Province
  • National Natural Science Foundation of China

Zitieren

APA

Wang, Y., Xiang, P., Li, Y., Wu, Y., Cai, H., & Luo, K. (2026). Tumor Microenvironmental Stimuli‐Responsive Linear‐Dendritic Polymeric Conjugate as Potential Nanomedicine. Macromolecular Rapid Communications, 47(11). https://doi.org/10.1002/marc.70258

Vancouver

Wang Y, Xiang P, Li Y, Wu Y, Cai H, Luo K. Tumor Microenvironmental Stimuli‐Responsive Linear‐Dendritic Polymeric Conjugate as Potential Nanomedicine. Macromolecular Rapid Communications. 2026;47(11). doi:10.1002/marc.70258

BibTeX
@article{Wang2026,
  author = {Wang, Yongchao and Xiang, Pan and Li, Yinggang and Wu, Yahui and Cai, Hao and Luo, Kui},
  title = {Tumor Microenvironmental Stimuli‐Responsive Linear‐Dendritic Polymeric Conjugate as Potential Nanomedicine},
  journal = {Macromolecular Rapid Communications},
  year = {2026},
  volume = {47},
  number = {11},
  doi = {10.1002/marc.70258}
}
Kostenlos starten →